Investigation On Disclosure Of Environmental Information By Pharmaceutical Corporations

The deficient natural resources and environmental pollution had become increasing prominentsocial issues nowadays. People ignored the sustainable development in pursuit of the process ofindustrialization. Such aggressive behavior at the cost of environment directly led the current status ofglobal warming, resource scarcity and haze in in the sky. It is well known that the good econogicalenvironment is the precondition of the social development, production and human health. To this end, ourgovernment had also invested significant costs and efforts to deal with environmental problems. In2005,the proposal of construction of “resource-saving and environment-friendly” society was raised, then the18th National Congress of the Communist Party made the “five in one” strategic layout, and at the NationalPeople’s Congress and the Chinese Political Consultative Conference(NPC&CPPCC) in2014, the Premierli Keqiang declared to fight with pollutions like treats to poverty. All of the above-mentioned conducts hadfully reflected the confidence of our government to protect the environments. Besides this, the authorityhad also stipulated that the pollluting industry should take actions to protect the environment andimplement precautionary measures during their productive process. In the mean time, the enterprises shoulddisclose their environmental activities in the financial reports. In this way, the external informantiondemanders could make a more realistic and comprehensive understanding on the business situation of theenterprises, and thereby give examinations on their environmental performance.The emphasis on sustainable development and environmental protection today, choose theaccounting field in the less mature environment accounting for the study. Environmental accounting inChina begins late and the development is relatively slow. most of the study is focus on a single industry orgeographic scope of pollution, through disclosuring of information collection, sorting, summarizing,point out how to discover its existence questions, suggest improvements or solutions. Pharmaceuticalcompanies, as a heavy polluting industries, should be taken to devote more funds to prevent environmentor reduce environmental pollution, but also has obligation to be relevant environmental accountinginformation to be disclosed, to ensure stakeholders ’ right of information. It is based on the environmentalaccounting information disclosure pharmaceutical industry to study individual enterprises, targeted measures and point out suggestions to improve the disclosure mode, find a reasonable approach andimprove a mode of corporate information to give pharmaceutical companies to provide the appropriateinformation disclosure model reference, to achieve the reference to point to the surface effect.This paper, it takes both researching and case studying, include environmental accounting andsustainable development, the asymmetric information theory, the stakeholder theory, consolidated andanalyzed the question of environmental accounting information disclosure in our country. In this context,review of A pharmaceutical companies2010-2012financial report, the directors’ report, prospectus andsocial responsibility report, does not find any information the disclosure of quantitative informationmonetization, or finds qualitative description of the main accounting and information disclosure less,arbitrary, no substantive information disclosure, disclosure of the overall situation can not meet theinformation needs of stakeholders. After checking leading pharmaceutical companies and access to parts ofthe past three years, environmental information disclosure status, such as "pollution scandal " after theHarbin Pharmaceutical shares, AoDong, Hualan, Yunnan baiyao, Tong Ren Tang, etc, finding that mostcompanies are only in the annual report social responsibilities under the column briefly mentioned, there isno relevant information through a third-party auditing, supervision, inadequate disclosure obvioussimilarities, the overall disclosure is not high quality.Facing of the overall situation in the pharmaceutical companies situation with carefullyanalysising, we summed up the A pharmaceutical companies to disclose in their own environment problemsreflected deep-seated reasons and problems one by one analysis, which raised A pharmaceutical corporateenvironmental information disclosure quality is not high impact factors, targeted recommendations forimprovement. A high manager in the pharmaceutical companies to improve disclosure of awareness,strengthen the professional quality of employees and citizens to enhance the awareness of environmentalprotection at the same time, methods and content of information disclosure issue A pharmaceuticalcompanies exist to give advisory solutions, the enterprise information disclosure mode to supplement,improve, enhance their quality of information disclosure.A pharmaceutical companies, for the study of environmental accounting information disclosureand by improving the traditional accounting statements, joined the environmental issues part of the actualsituation of enterprises according to their own environmental business accounting,included in the results table. The new report can reflect not only traditional accounting information, but also business-relatedactivities on the environment, which is not only an improvement on environmental accounting informationdisclosure model to explore, but also convenient external users access to corporate real, comprehensiveoperating conditions, make the right investment decisions. It can effectively promote corporate socialresponsibility, establish a good corporate image, promote the implementation of external supervision.